Diagnostic Medical Systems S.A. (EPA:ALDMS)

France · Delayed Price · Currency is EUR

1.045

+0.010 (0.97%)

Aug 21, 2026, 4:50 PM CET

-26.92% (1Y)

Market Cap	27.08M -5.8%
Revenue (ttm)	52.86M +8.2%
Net Income	-167.00K
EPS	-0.01
Shares Out	25.92M
PE Ratio	n/a
Forward PE	34.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,489
Open	1.035
Previous Close	1.035
Day's Range	1.035 - 1.050
52-Week Range	1.015 - 1.485
Beta	0.68
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 14, 2026

About EPA:ALDMS

Diagnostic Medical Systems S.A. designs, develops, manufactures, and sells medical imaging systems in France. The company offers ADAM, a software suite for imaging experts; R and F solutions, including Platinum Neo, Platinum Flex, and Optima; bone densitometers, including Stratos and Medix Series; MISTRAL, a manual chest and bone solution; and Camargue series which offers motorized radiographic systems to perform all types of bone and chest exams, including full spine and long leg exams. It also provides mobiles under the !M1, ONYX, Rafale/Rafa... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1979

Employees 146

Stock Exchange Euronext Paris

Ticker Symbol ALDMS

Full Company Profile

Financial Performance

In 2025, EPA:ALDMS's revenue was 52.86 million, an increase of 8.19% compared to the previous year's 48.86 million. Losses were -167,000, -94.20% less than in 2024.

Financial Statements